CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-08 | Degnan Chris Chief Financial Officer | Option exercise | +4,483 | 6,763 | ||
| 2026-10-08 | Degnan Chris Chief Financial Officer | Sale | −2,202 | $36.69 | $81K | 4,561 |
| 2026-10-08 | Degnan Chris Chief Financial Officer | Option exercise · Restricted Stock Units | −4,483 | 4,484 | ||
| 2026-09-08 | Schoenberg Mark Chief Medical Officer | Sale | −871 | $42.92 | $37K | 59,882 |
| 2026-09-08 | Smith Jason Drew General Counsel | Sale | −1,519 | $42.54 | $65K | 53,141 |
| 2026-09-07 | Schoenberg Mark Chief Medical Officer | Option exercise | +1,667 | 60,753 | ||
| 2026-09-07 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −1,667 | 0 | ||
| 2026-09-07 | Smith Jason Drew General Counsel | Option exercise | +3,334 | 54,660 | ||
| 2026-09-07 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −3,334 | 0 | ||
| 2026-08-26 | Robinson James A. Jr. Director | Option exercise | +2,000 | 8,000 | ||
| 2026-08-26 | Robinson James A. Jr. Director | Option exercise · Restricted Stock Unit | −2,000 | 0 | ||
| 2026-08-20 | Schoenberg Mark Chief Medical Officer | Sale | −60,677 | $47.05 | $2.9M | 59,086 |
| 2026-07-09 | Schoenberg Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $40.00 | $400K | 119,763 |
| 2026-06-22 | Schoenberg Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $35.01 | $350K | 129,763 |
| 2026-06-22 | Wildman Daniel George Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2026-06-22 | Wildman Daniel George Director | Grant or award · Restricted Stock Unit | +8,000 | 8,000 | ||
| 2026-06-22 | Robinson James A. Jr. Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2026-06-22 | Robinson James A. Jr. Director | Grant or award · Restricted Stock Unit | +8,000 | 8,000 | ||
| 2026-06-22 | Holden Stuart Director | Grant or award · Stock Option (right ot buy) | +20,000 | 20,000 | ||
| 2026-06-22 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 |
Page 1 of 13 · 244 trades